Burzynski Research Institute, Inc. (BZYR)

OTCMKTS · Delayed Price · Currency is USD
0.0289
+0.0039 (15.60%)
Mar 9, 2026, 10:05 AM EST
-50.09%
Market Cap 3.29M
Revenue (ttm) n/a
Net Income (ttm) -1.29M
Shares Out 131.45M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 15,998
Open 0.0289
Previous Close 0.0250
Day's Range 0.0289 - 0.0289
52-Week Range 0.0170 - 0.0550
Beta 0.28
RSI 49.87
Earnings Date May 28, 2026

About BZYR

Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1977
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol BZYR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.